Start SIP in CAMLINFINE
Start SIPPerformance
- Low
- ₹126
- High
- ₹134
- 52 Week Low
- ₹80
- 52 Week High
- ₹140
- Open Price₹128
- Previous Close₹128
- Volume1,234,273
Investment Returns
- Over 1 Month + 8.49%
- Over 3 Month + 26.24%
- Over 6 Month + 23.71%
- Over 1 Year -1.67%
Smart Investing Starts Here Start SIP with Camlin Fine Sciences for Steady Growth!
Camlin Fine Sciences Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- -9.9
- PEG Ratio
- 0
- Market Cap Cr
- 2,215
- P/B Ratio
- 2.7
- Average True Range
- 5.99
- EPS
- 0
- Dividend Yield
- 0
- MACD Signal
- 2.95
- RSI
- 67.04
- MFI
- 86.03
Camlin Fine Sciences Financials
Camlin Fine Sciences Technicals
EMA & SMA
Current Price
₹132.25
+
4.6
(3.6%)
- Bullish Moving Average 16
- Bearish Moving Average 0
- 20 Day
- ₹123.42
- 50 Day
- ₹117.71
- 100 Day
- ₹113.68
- 200 Day
- ₹114.43
Resistance and Support
130.76
- R3 144.60
- R2 139.49
- R1 135.87
- S1 127.14
- S2 122.03
- S3 118.41
Camlin Fine Sciences Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2024-11-22 | Rights issue of Equity Shares | Rs.0.00 alia, to consider : 1. The revision of the quantum of the proposed Rights isue to an amount not exceeding Rs. 225 crores; and 2. Issue of any debt securities of the Company. |
2024-11-11 | Quarterly Results | |
2024-08-12 | Quarterly Results | |
2024-05-20 | Audited Results | |
2024-02-09 | Quarterly Results |
Camlin Fine Sciences F&O
About Camlin Fine Sciences
- NSE Symbol
- CAMLINFINE
- BSE Symbol
- 532834
- Chairman & Managing Director
- Mr. Ashish Dandekar
- ISIN
- INE052I01032
Similar Stocks to Camlin Fine Sciences
Camlin Fine Sciences FAQs
Camlin Fine Sciences share price is ₹132 As on 28 December, 2024 | 00:21
The Market Cap of Camlin Fine Sciences is ₹2215.1 Cr As on 28 December, 2024 | 00:21
The P/E ratio of Camlin Fine Sciences is -9.9 As on 28 December, 2024 | 00:21
The PB ratio of Camlin Fine Sciences is 2.7 As on 28 December, 2024 | 00:21
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.